Security key
427746102
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)
CUSIP: 427746102
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 182,615,507
- Total 13F shares
- 156,540,717
- Share change
- -49,970
- Total reported value
- $125,245,868
- Put/Call ratio
- 190%
- Price per share
- $0.80
- Number of holders
- 162
- Value change
- -$7,261,306
- Number of buys
- 77
- Number of sells
- 69
Report period
Q1 2026
Institutions
162
Top holders
10
HRTX full security history
Previous quarter: Q4 2025
HERON THERAPEUTICS, INC. /DE/ SEC filings
HERON THERAPEUTICS, INC. /DE/ company facts
Broader feeds
Reporting periods
Holder history for CUSIP 427746102
Recent filing periods:
Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP |
13F
13D/G
3/4/5
|
Company · 10%+ Owner |
16%
from 13D/G
|
30,046,828
|
$39,060,876 | — | 31 Dec 2025 | |
| Clearline Capital LP |
13D/G
13F
|
Company |
6.7%
|
12,235,239
|
$18,108,154 | +$3,733,614 | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
6.1%
|
11,185,325
|
$14,540,923 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
5.6%
|
10,218,236
|
$13,283,708 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.4%
|
9,820,384
|
$12,766,499 | — | 31 Dec 2025 | |
| Velan Capital Investment Management LP |
13F
3/4/5
|
Company · Other* |
4.8%
|
8,753,290
|
$11,379,277 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.9%
|
7,169,908
|
$9,320,880 | — | 31 Dec 2025 | |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
|
Company |
3.5%
|
6,326,113
|
$8,223,947 | — | 31 Dec 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.4%
|
6,250,000
|
$8,125,000 | — | 31 Dec 2025 | |
| Tejara Capital Ltd |
13F
|
Company |
2.8%
|
5,131,426
|
$6,670,854 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
4,081,222
|
$5,306,435 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
3,778,043
|
$4,911,456 | — | 31 Dec 2025 | |
| JW Asset Management, LLC |
13F
|
Company |
2%
|
3,671,073
|
$4,772,395 | — | 31 Dec 2025 | |
| Congress Park Capital LLC |
13F
|
Company |
1.7%
|
3,067,475
|
$3,987,718 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.6%
|
3,004,640
|
$3,906,032 | — | 31 Dec 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
1.4%
|
2,576,716
|
$3,349,731 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
2,095,045
|
$2,723,559 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
1.1%
|
2,091,669
|
$2,719,170 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1%
|
1,915,900
|
$2,490,670 | — | 31 Dec 2025 | |
| Pale Fire Capital SE |
13F
|
Company |
0.8%
|
1,469,655
|
$1,910,552 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
1,415,336
|
$1,839,937 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.75%
|
1,367,891
|
$1,778,259 | — | 31 Dec 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.68%
|
1,237,802
|
$1,609,143 | — | 31 Dec 2025 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.68%
|
1,233,022
|
$1,602,929 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
1,091,411
|
$1,418,835 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.55%
|
999,509
|
$1,299,362 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
989,796
|
$1,286,735 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.53%
|
963,851
|
$1,253,007 | — | 31 Dec 2025 | |
| CM Management, LLC |
13F
|
Company |
0.41%
|
750,000
|
$975,000 | — | 31 Dec 2025 | |
| Orchard Capital Management, LLC |
13F
|
Company |
0.37%
|
680,432
|
$884,562 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.37%
|
677,947
|
$881,331 | — | 31 Dec 2025 | |
| Richmond Brothers, Inc. |
13F
|
Company |
0.31%
|
572,118
|
$743,755 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.28%
|
519,571
|
$675,442 | — | 31 Dec 2025 | |
| NEXPOINT ASSET MANAGEMENT, L.P. |
13F
|
Company |
0.26%
|
475,750
|
$618,475 | — | 31 Dec 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.24%
|
440,252
|
$572,328 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
418,477
|
$544,020 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
376,300
|
$489,189 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.19%
|
347,065
|
$451,185 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.19%
|
340,246
|
$442,320 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.17%
|
307,861
|
$400,220 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.17%
|
303,209
|
$394,172 | — | 31 Dec 2025 | |
| Apeiron RIA LLC |
13F
|
Company |
0.14%
|
259,968
|
$358,756 | — | 31 Dec 2025 | |
| Palumbo Wealth Management LLC |
13F
|
Company |
0.14%
|
259,413
|
$337,237 | — | 31 Dec 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
248,567
|
$283,366 | — | 31 Dec 2025 | |
| Cyndeo Wealth Partners, LLC |
13F
|
Company |
0.14%
|
248,087
|
$322,513 | — | 31 Dec 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
242,000
|
$314,600 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.13%
|
240,197
|
$312,256 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.12%
|
227,784
|
$296,119 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.11%
|
203,319
|
$264,305 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.11%
|
198,550
|
$258,115 | — | 31 Dec 2025 |
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2026
As of 31 Mar 2026,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
162 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
156,540,717 shares.
The largest 10 holders included
Rubric Capital Management LP, Clearline Capital LP, BlackRock, Inc., ORBIMED ADVISORS LLC, Velan Capital Investment Management LP, VANGUARD CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Tejara Capital Ltd, TANG CAPITAL MANAGEMENT LLC, and PALISADE CAPITAL MANAGEMENT, LP.
This page lists
162
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
170
Q1 2026 holders
162
Holder diff
-8
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.